keyword
https://read.qxmd.com/read/38477038/next-generation-sequencing-based-identification-of-enterobacter-hormaechei-as-causative-agent-of-high-mortality-disease-in-nod-cg-prkdc-scid-il2rg-tm1wjl-szj-nsg-mice
#21
JOURNAL ARTICLE
Catherine Si, Kourtney Nickerson, Taylor Simmons, Parker Denton, M Russell Nichols, Robert C Dysko, Mark Hoenerhoff, Rinosh Mani, Cheryl Woods, Kenneth S Henderson, Zachary T Freeman
NOD.Cg- Prkdcscid Il2rgtm1Wjl /SzJ (NSG) mice, lacking many components of a mature immune system, are at increased risk of disease. General understanding of potential pathogens of these mice is limited. We describe a high mortality disease outbreak caused by an opportunistic bacterial infection in NSG mice. Affected animals exhibited perianal fecal staining, dehydration, and wasting. Histopathologic lesions included a primary necrotizing enterocolitis, with inflammatory and necrotizing lesions also occurring in the liver, kidneys, heart, and brain of some mice...
March 13, 2024: Toxicologic Pathology
https://read.qxmd.com/read/38475968/large-scale-bioreactor-production-of-extracellular-vesicles-from-mesenchymal-stromal-cells-for-treatment-of-acute-radiation-syndrome
#22
JOURNAL ARTICLE
John A Kink, Michael A Bellio, Matthew H Forsberg, Alexandra Lobo, Anna S Thickens, Bryson M Lewis, Irene M Ong, Aisha Khan, Christian M Capitini, Peiman Hematti
BACKGROUND: Hematopoietic acute radiation syndrome (H-ARS) occurring after exposure to ionizing radiation damages bone marrow causing cytopenias, increasing susceptibility to infections and death. We and others have shown that cellular therapies like human mesenchymal stromal cells (MSCs), or monocytes/macrophages educated ex-vivo with extracellular vesicles (EVs) from MSCs were effective in a lethal H-ARS mouse model. However, given the complexity of generating cellular therapies and the potential risks of using allogeneic products, development of an "off-the-shelf" cell-free alternative like EVs may have utility in conditions like H-ARS that require rapid deployment of available therapeutics...
March 13, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38475814/cd19-cd20-dual-targeted-chimeric-antigen-receptor-engineered-natural-killer-cells-exhibit-improved-cytotoxicity-against-acute-lymphoblastic-leukemia
#23
JOURNAL ARTICLE
Na Yang, Caili Zhang, Yingchun Zhang, Yuting Fan, Jing Zhang, Xiaojin Lin, Ting Guo, Yangzuo Gu, Jieheng Wu, Jianmei Gao, Xing Zhao, Zhixu He
BACKGROUND: Chimeric antigen receptor natural killer (CAR-NK) cells represent a promising advancement in CAR cell therapy, addressing limitations observed in CAR-T cell therapy. However, our prior study revealed challenges in CAR-NK cells targeting CD19 antigens, as they failed to eliminate CD19+ Raji cells in NSG tumor-bearing mice, noting down-regulation or loss of CD19 antigen expression in some Raji cells. In response, this study aims to enhance CD19 CAR-NK cell efficacy and mitigate the risk of tumor recurrence due to target antigen escape by developing CD19 and CD20 (CD19/CD20) dual-targeted CAR-NK cells...
March 13, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38471646/three-dimensional-chromatin-analysis-reveals-sp1-as-a-mediator-to-program-and-reprogram-hpv-host-epigenetic-architecture-in-cervical-cancer
#24
JOURNAL ARTICLE
Canhui Cao, Qian Xu, Zhixian Zhu, Miaochun Xu, Ye Wei, Shitong Lin, Sheng Cheng, Wenhua Zhi, Ping Hong, Xingyu Huang, Da Lin, Gang Cao, Yifan Meng, Ping Wu, Ting Peng, Juncheng Wei, Wencheng Ding, Xiaoyuan Huang, WingKin Sung, Gang Chen, Ding Ma, Guoliang Li, Peng Wu
Human papillomavirus (HPV) is predominantly associated with HPV-related cancers, however, the precise mechanisms underlying the HPV-host epigenetic architectures in HPV carcinogenesis remain elusive. Here, we employed high-throughput chromosome conformation capture (Hi-C) to comprehensively map HPV16/18-host chromatin interactions. Our study identified the transcription factor Sp1 as a pivotal mediator in programming HPV-host interactions. By targeting Sp1, the active histone modifications (H3K27ac, H3K4me1, and H3K4me3) and the HPV-host chromatin interactions are reprogrammed, which leads to the downregulation of oncogenes located near the integration sites in both HPV (E6/E7) and the host genome (KLF5/MYC)...
March 10, 2024: Cancer Letters
https://read.qxmd.com/read/38464203/hu8f4-car-t-cells-with-mutated-fc-spacer-segment-improve-target-specificity-and-mediate-anti-leukemia-activity-in-vivo
#25
Jeffrey Molldrem, Hong He, Rolando Vedia, Sijie Lu, Qiaochuan Li, Kathryn Cox, Lisa St John, Anna Sergeeva, Karen Clise-Dwyer, Gheath Alatrash, Elizabeth Shpall, Qing Ma
Hu8F4 is a T cell receptor (TCR)-like antibody with high affinity for leukemia-associated antigen PR1/HLA-A2 epitope. Adapted into a chimeric antigen receptor (CAR) format, Hu8F4-CAR is comprised of the Hu8F4 scFv, the human IgG1 CH2CH3 extracellular spacer domain, a human CD28 costimulatory domain, and the human CD3ζ signaling domain. We have demonstrated high efficacy of Hu8F4-CAR-T cells against PR1/HLA-A2-expressing cell lines and leukemic blasts from AML patients in vitro. Previous studies have shown that modification of the Fc domains of IgG4 CH2CH3 spacer regions can eliminate activation-induced cell death and off-target killing mediated by mouse Fc gamma receptor (FcgR)-expressing cells...
February 19, 2024: Research Square
https://read.qxmd.com/read/38461534/simultaneously-engineering-the-first-and-second-coordination-shells-of-single-iron-catalysts-for-enhanced-oxygen-reduction
#26
JOURNAL ARTICLE
Kai Chi, Zhuoping Wang, Tao Sun, Peng He, Fei Xiao, Jiong Lu, Shuai Wang
The atomically dispersed Fe-N4 active site presents enormous potential for various renewable energy conversions. Despite its already remarkable catalytic performance, the local atomic microenvironment of each Fe atom can be regulated to further enhance its efficiency. Herein, a novel conceptual strategy that utilizes a simple salt-template polymerization method to simultaneously adjust the first coordination shell (Fe-N3 S1 ) and second coordination shell (C-S-C, a structure similar to thiophene) of Fe-N4 isolated atoms is proposed...
March 10, 2024: Small
https://read.qxmd.com/read/38447268/in-vivo-and-in-vitro-effects-of-cord-blood-hematopoietic-stem-and-progenitor-cell-hspc-expansion-using-valproic-acid-and-or-nicotinamide
#27
JOURNAL ARTICLE
Emine Begum Gencer, Hasan Yalim Akin, Selami Kocak Toprak, Eylul Turasan, Mahsa Yousefzadeh, Pinar Yurdakul-Mesutoglu, Murat Cagan, Mehmet Murat Seval, Doruk Cevdi Katlan, Klara Dalva, Mehmet Sinan Beksac, Meral Beksac
BACKGROUND: High self-renewal capacity and most permissive nature of umbilical cord blood (CB) results with successful transplant outcomes but low hematopoietic stem and progenitor cell (HSPC) counts limits wider use. In order to overcome this problem ex vivo expansion with small molecules such as Valproic acid (VPA) or Nicotinamide (NAM) have been shown to be effective. To the best of our knowledge, the combinatory effects of VPA and NAM on HSPC expansion has not been studied earlier...
March 1, 2024: Current Research in Translational Medicine
https://read.qxmd.com/read/38445374/biodistribution-and-safety-of-human-multi-chimeric-cells-hmcc-after-systemic-intraosseous-and-intravenous-administration-in-the-experimental-mouse-model
#28
JOURNAL ARTICLE
Maria Siemionow, Lucile Chambily, Joanna Cwykiel
Cellular therapies provide promising options for inducing tolerance in transplantation of solid organs, bone marrow, and vascularized composite allografts. However, novel tolerance-inducing protocols remain limited despite extensive research. We previously introduced and characterized a Human Multi-Chimeric Cell (HMCC) line, created through ex vivo fusion of human umbilical cord blood (UCB) cells derived from three unrelated donors. In this study, we assessed in vivo biodistribution and safety of HMCC in the NOD...
March 6, 2024: Stem Cells and Development
https://read.qxmd.com/read/38438561/cell-mediated-exon-skipping-normalizes-dystrophin-expression-and-muscle-function-in-a-new-mouse-model-of%C3%A2-duchenne-muscular-dystrophy
#29
JOURNAL ARTICLE
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, Marco Bagicaluppi, Rossana Tonlorenzi, Tendai Sibanda, Miriam Caffarini, Avraneel Talapatra, Sabrina Santoleri, Mirella Meregalli, Beatriz Bano-Otalora, Anne Bigot, Irene Bozzoni, Chiara Bonini, Vincent Mouly, Yvan Torrente, Giulio Cossu
Cell therapy for muscular dystrophy has met with limited success, mainly due to the poor engraftment of donor cells, especially in fibrotic muscle at an advanced stage of the disease. We developed a cell-mediated exon skipping that exploits the multinucleated nature of myofibers to achieve cross-correction of resident, dystrophic nuclei by the U7 small nuclear RNA engineered to skip exon 51 of the dystrophin gene. We observed that co-culture of genetically corrected human DMD myogenic cells (but not of WT cells) with their dystrophic counterparts at a ratio of either 1:10 or 1:30 leads to dystrophin production at a level several folds higher than what predicted by simple dilution...
March 4, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38435424/enhanced-potency-of-immunotherapy-against-b-cell-precursor-acute-lymphoblastic-leukemia-by-combination-of-an-fc-engineered-cd19-antibody-and-cd47-blockade
#30
JOURNAL ARTICLE
Denis M Schewe, Fotini Vogiatzi, Ira A Münnich, Tobias Zeller, Roland Windisch, Christian Wichmann, Kristina Müller, Hilal Bhat, Elisa Felix, Dimitrios Mougiakakos, Heiko Bruns, Lennart Lenk, Thomas Valerius, Andreas Humpe, Matthias Peipp, Christian Kellner
CD19-directed immunotherapy has become a cornerstone in the therapy of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). CD19-directed cellular and antibody-based therapeutics have entered therapy of primary and relapsed disease and contributed to improved outcomes in relapsed disease and lower therapy toxicity. However, efficacy remains limited in many cases due to a lack of therapy response, short remission phases, or antigen escape. Here, BCP-ALL cell lines, patient-derived xenograft (PDX) samples, human macrophages, and an in vivo transplantation model in NOD...
February 2024: HemaSphere
https://read.qxmd.com/read/38433905/engraftment-of-adult-hematopoietic-stem-and-progenitor-cells-in-a-novel-model-of-humanized-mice
#31
JOURNAL ARTICLE
Chun I Yu, Rick Maser, Florentina Marches, Jacques Banchereau, Karolina Palucka
Pre-clinical use of humanized mice transplanted with CD34+ hematopoietic stem and progenitor cells (HSPCs) is limited by insufficient engraftment with adult non-mobilized HSPCs. Here, we developed a novel immunodeficient mice based on NOD-SCID- Il2γc -/- (NSG) mice to support long-term engraftment with human adult HSPCs. As both Flt3L and IL-6 are critical for many aspects of hematopoiesis, we knock-out mouse Flt3 and knock-in human IL6 gene. The resulting mice showed an increase in the availability of mouse Flt3L to human cells and a dose-dependent production of human IL-6 upon activation...
March 15, 2024: IScience
https://read.qxmd.com/read/38429643/single-cell-rna-sequencing-reveals-peripheral-blood-leukocyte-responses-to-spinal-cord-injury-in-mice-with-humanised-immune-systems
#32
JOURNAL ARTICLE
Ellen R Gillespie, Laura F Grice, Isabel G Courtney, Hong Wa Lao, Woncheol Jung, Sonny Ramkomuth, Jacky Xie, David A Brown, James Walsham, Kristen J Radford, Quan H Nguyen, Marc J Ruitenberg
Next-generation humanised mouse models and single-cell RNA sequencing (scRNAseq) approaches enable in-depth studies into human immune cell biology. Here we used NSG-SGM3 mice engrafted with human umbilical cord haematopoietic stem cells to investigate how human immune cells respond to and/or are changed by traumatic spinal cord injury (SCI). We hypothesised that the use of such mice could help advance our understanding of spinal cord injury-induced immune depression syndrome (SCI-IDS), and also how human leukocytes change as they migrate from the circulation into the lesion site...
March 1, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38421044/an-orally-efficacious-thyrotropin-receptor-ligand-inhibits-growth-and-metastatic-activity-of-thyroid-cancers
#33
JOURNAL ARTICLE
Rhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor, Elena Eliseeva, Andrés E Dulcey, Jay S Templin, Amy Q Wang, Xin Xu, Noel Southall, Joanna Klubo-Gwiezdzinska, Susanne Neumann, Juan J Marugan, Marvin C Gershengorn
CONTEXT: Thyroid-stimulating hormone (or thyrotropin) receptor (TSHR) could be a selective target for small molecule ligands to treat thyroid cancer (TC). OBJECTIVE: We report a novel, orally efficacious ligand for TSHR that exhibits proliferation inhibitory activity against human TC in vitro and in vivo, and inhibition of metastasis in vivo. DESIGN: A35 (NCATS-SM4420; NCGC00241808) was selected from a sub-library of >200 TSHR ligands. Cell proliferation assays including BrdU incorporation and WST-1, along with molecular docking studies were done...
February 29, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38419094/the-combined-application-of-hand-hygiene-and-non-sterile-gloves-by-nurses-in-a-tertiary-hospital-a-multi-methods-study
#34
JOURNAL ARTICLE
Mireille Dekker, Rosa van Mansfeld, Marjon Borgert, Jolanda Maaskant, Frederique Paulus, Annamarike Seller, Irene P Jongerden
BACKGROUND: The application of hand hygiene (HH) and the use of non-sterile gloves (NSG) in daily care is highly intertwined. We aimed (1) to assess the combined application of HH and NSG among nurses and (2) to explore determinants that influence their ability to combine both measures in their care. METHODS: In a multi-methods study, we combined direct observations of care episodes with semi-structured interviews with nurses in two affiliated university hospitals...
February 28, 2024: Antimicrobial Resistance and Infection Control
https://read.qxmd.com/read/38418146/development-of-a-simple-and-reproducible-cell-derived-orthotopic-xenograft-murine-model-for-neuroblastoma
#35
JOURNAL ARTICLE
Kathleen Doyle, Abd-Elrahman Hassan, Maria Sutter, Monica Rodriguez, Priyadarsini Kumar, Erin Brown
BACKGROUND/AIM: Neuroblastoma is a common childhood cancer with poor survival for children with high-risk disease, and ongoing research to improve outcomes is needed. Patient-derived xenografts (PDX) and genetically engineered mouse models (GEMM) are reliable models for oncologic research; however, they are resource-intensive, expensive, and require significant expertise to develop and maintain. We developed an orthotopic xenograft murine model of neuroblastoma that utilizes cryopreserved banks of human neuroblastoma cell lines, requires minimal equipment, and is easily reproducible...
2024: In Vivo
https://read.qxmd.com/read/38415653/a-novel-lentiviral-vector-based-approach-to-generate-chimeric-antigen-receptor-t-cells-targeting-aspergillus-fumigatus
#36
JOURNAL ARTICLE
Pappanaicken R Kumaresan, Sebastian Wurster, Karishma Bavisi, Thiago Aparecido da Silva, Paul Hauser, Jordan Kinnitt, Nathaniel D Albert, Uddalak Bharadwaj, Sattva Neelapu, Dimitrios P Kontoyiannis
Invasive aspergillosis (IA) is a common and deadly mold infection in immunocompromised patients. As morbidity and mortality of IA are primarily driven by poor immune defense, adjunct immunotherapies, such as chimeric antigen receptor (CAR) T cells, are direly needed. Here, we propose a novel approach to generate Aspergillus fumigatus (AF)-CAR T cells using the single-chain variable fragment domain of monoclonal antibody AF-269-5 and a lentiviral vector system. These cells successfully targeted mature hyphal filaments of representative clinical and reference AF isolates and elicited a potent release of cytotoxic effectors and type 1 T cell cytokines...
February 28, 2024: MBio
https://read.qxmd.com/read/38411611/near-infrared-dye-ir-780-alleviates-hematopoietic-system-damage-by-promoting-hematopoietic-stem-cells-into-quiescence
#37
JOURNAL ARTICLE
Jie Wu, Le Ma, Qiang Gong, Yan Chen, Long Chen, Chunmeng Shi
Worrying about potential radiation exposure is a general concern, but no effective pre-exposure radioprotective countermeasure is generally accepted1. Here, we found a small molecular near-infrared (NIR) dye IR-780, which promoted hematopoietic stem cells (HSCs) into quiescence to resist stress. When mice were treated with IR-780 before stress, increased HSC quiescence and better hematopoietic recovery were observed in IR-780-treated mice in stress conditions. However, when given after radiation, IR-780 did not show obvious benefit...
February 27, 2024: Shock
https://read.qxmd.com/read/38407894/high-dimensional-analyses-reveal-il-15-enhances-activation-of-sipuleucel-t-lymphocyte-subsets-and-reverses-immunoresistance
#38
JOURNAL ARTICLE
Muhammad A Saeed, Bo Peng, Kevin Kim, Kavita Rawat, Lindsey M Kuehm, Zoe R Siegel, Ariel Borkowski, Nabih Habib, Brian Van Tine, Nadeem Sheikh, Vu Tuyen, Daniel L J Thorek, Todd A Fehniger, Russell K Pachynski
Sipuleucel-T (sip-T) is the only FDA-approved autologous cellular immunotherapy for metastatic castration-resistant prostate cancer (mCRPC). To elucidate parameters of the response profile to this therapy, we report high-dimensional analyses of sip-T using cytometry by time of flight (CyTOF) and show a lymphoid predominance, with CD3+ T cells constituting the highest proportion (median ~60%) of sip-T, followed by B cells, and natural killer (NK) and NKT cells. We hypothesized that treatment of sip-T with homeostatic cytokines known to activate/expand effector lymphocytes could augment efficacy against prostate tumors...
February 26, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38399364/accelerated-neuroimmune-dysfunction-in-aged-hiv-1-infected-humanized-mice
#39
JOURNAL ARTICLE
Chen Zhang, Hang Su, Emiko Waight, Larisa Y Poluektova, Santhi Gorantla, Howard E Gendelman, Prasanta K Dash
Disordered immunity, aging, human immunodeficiency virus type one (HIV-1) infection, and responses to antiretroviral therapy are linked. However, how each factor is linked with the other(s) remains incompletely understood. It has been reported that accelerated aging, advanced HIV-1 infection, inflammation, and host genetic factors are associated with host cellular, mitochondrial, and metabolic alterations. However, the underlying mechanism remains elusive. With these questions in mind, we used chronically HIV-1-infected CD34-NSG humanized mice (hu-mice) to model older people living with HIV and uncover associations between HIV-1 infection and aging...
January 23, 2024: Pharmaceuticals
https://read.qxmd.com/read/38378601/low-dose-hypomethylating-agents-cooperate-with-ferroptosis-inducers-to-enhance-ferroptosis-by-regulating-the-dna-methylation-mediated-magea6-ampk-slc7a11-gpx4-signaling-pathway-in-acute-myeloid-leukemia
#40
JOURNAL ARTICLE
Shuya Feng, Yigang Yuan, Zihan Lin, Min Li, Daijiao Ye, Liuzhi Shi, Danyang Li, Min Zhao, Chen Meng, Xiaofei He, Shanshan Wu, Fang Xiong, Siyu Ye, Junjun Yang, Haifeng Zhuang, Lili Hong, Shenmeng Gao
BACKGROUND: Ferroptosis is a new form of nonapoptotic and iron-dependent type of cell death. Glutathione peroxidase-4 (GPX4) plays an essential role in anti-ferroptosis by reducing lipid peroxidation. Although acute myeloid leukemia (AML) cells, especially relapsed and refractory (R/R)-AML, present high GPX4 levels and enzyme activities, pharmacological inhibition of GPX4 alone has limited application in AML. Thus, whether inhibition of GPX4 combined with other therapeutic reagents has effective application in AML is largely unknown...
February 20, 2024: Experimental Hematology & Oncology
keyword
keyword
94865
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.